文献速递胃肠外科

早期胃癌活检与最终切除组织学差异对治疗结局的影响

Effect of histologic differences between biopsy and final resection on treatment outcomes in early gastric cancer.
PubMed 文献 · Surg Endosc · 2019-12-09

该研究分析了1851例接受内镜切除或胃切除术的早期胃癌患者,比较活检与最终切除标本的组织学差异。内镜切除组组织学差异率为11.9%,胃切除组为10.7%。组织学差异可导致内镜切除非治愈性切除或胃切除错失内镜切除机会。

要点

  • 早期胃癌活检与最终切除组织学差异率约10%。
  • 内镜切除后组织学差异常致非治愈性切除。
  • 胃切除后组织学差异可能错失内镜切除机会。

核心结论

  • 约10%的早期胃癌患者活检与最终切除标本存在组织学差异。
  • 组织学差异可影响治疗结局,如内镜切除非治愈性切除或胃切除错失内镜切除机会。

研究设计与样本

  • 回顾性分析1851例接受内镜切除或胃切除术的早期胃癌患者数据。
  • 比较活检与最终切除标本的组织学,并分析组织学差异对治疗结局的影响。

主要发现

  • 内镜切除组组织学差异率为11.9%,胃切除组为10.7%。
  • 内镜切除组组织学差异者中,80.9%活检为分化型而最终切除为未分化型,其中78.9%为非治愈性切除。
  • 胃切除组组织学差异者中,39%活检为未分化型而最终切除为分化型,这些患者均具有内镜切除的绝对或扩大指征。
  • 活检中中度分化腺癌是未分化型最终切除的组织学差异预测因素,低分化腺癌是分化型最终切除的组织学差异预测因素。

临床怎么用

  • 临床决策时应警惕活检与最终病理的组织学差异可能。
  • 对内镜切除适应症的判断需综合考虑活检组织学类型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND STUDY AIMS: Biopsy-based histologic diagnosis is important in determining the treatment strategy for early gastric cancer (EGC). However, there are few studies on how histologic discrepancy may affect patients' treatment outcomes. We aimed to investigate the impact of histopathologic differences between biopsy and final specimens from endoscopic resection (ER) or gastrectomy on treatment outcomes in patients with EGC. We also examined the predictive factors of histologic discrepancy. PATIENTS AND METHODS: We analyzed the data of 1851 patients with EGC treated with ER or gastrectomy. We compared the histology between biopsies and final resected specimens from ER or gastrectomy. We also examined changes in treatment outcomes according to histologic differences. RESULTS: Histologic discrepancy was observed in 11.9% of patients in the ER group and 10.7% of those in the gastrectomy group. In patients treated with ER who showed histologic discrepancy, 80.9% showed differentiated-type EGC (D-EGC) on biopsy but undifferentiated-type-EGC (UD-EGC) after ER, of which 78.9% were non-curative resection. In patients treated with gastrectomy who showed histologic discrepancy, 39% showed UD-EGC on biopsy but showed D-EGC after gastrectomy. A total of these patients had absolute and expanded indications for ER. Moderately differentiated and poorly differentiated adenocarcinoma on biopsy were predictive factors of histologic discrepancy in UD-EGC and D-EGC on final resection, respectively. CONCLUSIONS: About 10% of patients showed histologic discrepancy between biopsy and final resection with ER or gastrectomy. Histologic discrepancy can affect treatment outcomes, such as non-curative resection in ER or missing the opportunity for ER in gastrectomy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Kim Y, Yoon HJ, Kim JH, et al. Effect of histologic differences between biopsy and final resection on treatment outcomes in early gastric cancer. Surg Endosc. 2019. PMID: 31820151. doi:10.1007/s00464-019-07301-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。